This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Lifecore Biomedical discloses DOJ, SEC investigation into potential FCPA matters at Mexico facility

( January 2, 2020, 11:59 GMT | Official Statement) -- MLex Summary: Pharmaceutical company Lifecore Biomedical has disclosed information to the US Department of Justice and the Securities and Exchange Commission regarding "potential compliance matters" concerns related to the Foreign Corrupt Practices Act in its operations at the Tanok facility in Mexico, according to a securities filing. The company said it is cooperating with both agencies in their investigations.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections